| Factors | Number of patients | Local control at 3 years (%) | Local control at 5 years (%) | P value (univariate) |
| Age (years) <60 ≥60 |
32 56 |
85.7 64.1 |
85.7 52.5 | 0.026 |
| Pretreatment Hemoglobin <12 g/dl ≥12 g/dl |
29 17 |
50.6 87.5 |
38.0 72.9 | 0.114 |
| Pathology Papillary Serous Clear cell Undifferentiated Carcinosarcoma |
28 12 8 40 |
71.9 85.7 All cases censored 57.0 |
61.6 85.7 All cases censored 42.7 | 0.140 |
| Lymph nodes Nx N0 N1 |
63 18 7 |
74.8 69.2 All cases censored |
60.1 69.2 All cases censored | 0.880 |
| FIGO stage Early (I,II) Advanced (III,IV) |
68 20 |
75.9 78.1 |
59.6 78.1 | 0.841 |
| Adjuvant ERBT No Yes |
9 79 |
57.1 79.6 |
38.1 70.5 | 0.111 |
| Brachytherapy Yes No |
49 39 |
85.7 66.3 |
78.6 49.8 | 0.075 |
| Chemotherapy Yes No |
8 78 |
64.3 77.1 |
64.3 63.5 | 0.919 |